PORTSMOUTH, NH--(Marketwire - April 14, 2010) -
As part of its continuing efforts to improve patient outcomes and reduce non-routine discharges for its hospital customers, Salient Surgical Technologies, Inc. today announced the availability of its line of AQUAMANTYS® bipolar sealers for use in orthopedic trauma procedures.
Already in wide use for spinal fusion and orthopedic reconstruction of the hip and knee, the AQUAMANTYS System can help the surgeon achieve hemostasis quickly while avoiding damage to delicate structures. Typical applications include lower limb amputation, pelvic osteotomy, and large debridement procedures; sacral, hip, periprosthetic and femoral fractures and long bone non-union procedures.
The AQUAMANTYS System employs TRANSCOLLATION technology, Salient's proprietary combination of radiofrequency energy and saline that seals specific types of collagen based tissues while maintaining temperatures at or below one-hundred degrees Celsius.
"Our customers tell us that the two things that matter most for good patient outcomes in orthopedic trauma cases are a good reduction and gentle tissue management," said Joseph F. Army, President and Chief Executive Officer of Salient. "The AQUAMANTYS System's ability to deliver gentle, low-temperature hemostasis makes this entry into trauma procedures a natural progression in the expanding adoption of TRANSCOLLATION technology."
About Salient Surgical Technologies
Salient Surgical Technologies, Inc. is a medical technology company that develops and markets advanced energy devices for use in surgical procedures. Salient's proprietary TRANSCOLLATION™ technology allows surgeons to rapidly treat tissue at the surgical site by transforming specific types of collagen based structures to improve patient outcomes. Salient's products are currently used in orthopedic reconstruction, spine and surgical oncology. To date, TRANSCOLLATION™ technology has been used in over 400,000 surgical procedures.